Bone mineral density and depot medroxyprogesterone acetate

Contraception

Volumn 73, Issue 6, 2006, Pages 577-583

  Albertazzi, Paola ^a   Bottazzi, Mirella ^b   Steel, Susan A ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Injectable contraception; Oral contraceptive pill; Peak bone mass; Progesterone

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FRACTURE; HIP; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR; SPINE;

ADULT; BODY MASS INDEX; BONE DENSITY; CALCIUM, DIETARY; CONTRACEPTIVES, ORAL, COMBINED; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK; SPINE;

EID: 33646872453     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.02.004     Document Type: Article

References (26)

1. Cromer B.A., Berg-Kelly K.S., Van Groningen J.P., Seimer B.S., and Ruusuvaara L. Depot medroxyprogesterone acetate (Depo-Provera) and levonorgestrel (Norplant) use in adolescents among clinics in Northern Europe and the United States. J Adolesc Health 23 (1998) 74-80
2. Cundy T., Cornish J., Roberts H., Elder H., and Reid I.R. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 92 (1998) 569-573
3. Paiva L.C., Pinto-Neto A.M., and Faundes A. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Contraception 58 (1998) 351-355
4. Tang O.S., Tang G., Yip P., Li B., and Fan S. Long-term depot-medroxyprogesterone acetate and bone mineral density. Contraception 59 (1999) 25-29
5. Naessen T., Olsson S.E., and Gudmundson J. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception 52 (1995) 35-39
6. Berenson A.B., Breitkopf C.R., Grady J.J., Rickert V.I., and Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 103 (2004) 899-906
7. Scholes D., Lacroix A.Z., Ott S.M., Ichikawa L.E., and Barlow W.E. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 93 (1999) 233-238
8. Lara-Torre E., Edwards C.P., Perlman S., and Hertweck S.P. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17 (2004) 17-21
9. http://www.fda.gov/medwatch/SAFETY/2004/DepoProvera_Label.pdf (accessed March 3, 2005).
10. http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessages/D epo-provera_letterhealthprofs_181104.pdf (accessed March 3, 2205).
11. Polatti F., Perotti F., Filippa N., Gallina D., and Nappi R.E. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221-224
12. Hartard M., Kleinmond C., Kirchbichler A., et al. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Bone 35 (2004) 836-841
13. Teenage Pregnancy Unit Statistics. http://www.dfes.gov.uk/teenagepregnancy. (accessed Dec 4, 2004).
14. Kmietowicz Z. US and UK are top in teenage pregnancy rates. BMJ 324 (2002) 1354
15. Gionet N.J., and Godin G. Self-reported exercise behaviour of employees: a validity study. J Occup Med 31 (1989) 969-973
16. Theinz G., Buchs B., Nizzolo R., et al. Longitudinal monitoring of bone mass accumulation in adolescents: evidence for a marked reduction after 16 years of age at the level of the lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 74 (1992) 1060-1065
17. Sabatier J.P., Guaydier-Souquieres G., Benmalek A., and Marcelli C. Evolution of lumbar bone mineral content during adolescence and adulthood: a longitudinal study in 395 healthy females 10-24 years of age and 206 premenopausal women. Osteoporos Int 9 (1999) 476-482
18. Hamed H.M., Purdie D.W., Ramsden C.S., Carmichael B., Steel S.A., and Howey S. Influence of birth weight on adult bone mineral density. Osteoporos Int 3 (1993) 1-2
19. Hansen M.A., Overgaard K., Riis B.J., and Christiansen C. Potential risk factors for development of postmenopausal osteoporosis-examined over a 12-year period. Osteoporos Int 1 (1991) 95-102
20. Banks E., Berrington A., and Casabonne D. Overview of the relationship between the use of progesterone-only contraceptives and bone mineral density. Br J Obstet Gynaecol 108 (2001) 1214-1221
21. Gibolade B.A. Depo Provera and bone density. Faculty aid to CPD Topics (FACT). J Fam Plann Reprod Health Care 28 (2002) 7-11
22. National diet and nutrition survey adults aged 19 to 64 years http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=9761 (accessed Dec 9, 2004).
23. National statistics: smoking. http://www.statistics.gov.uk/cci/nugget.asp?id=313 (accessed Dec 9, 2004).
24. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103 Suppl 2A (1997) 3S-8S [discussion 8S-11S]
25. Honkanen R., Tuppurainen M., Kroger H., Alhava E., and Puntila E. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 60 (1997) 327-331
26. Sanders K.M., Pasco J.A., Ugoni A.M., et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13 (1998) 1337-1342